Publications

06 Jun 2023
Cold Call Podcast

The Opioid Crisis, CEO Pay, and Shareholder Activism

Keywords: Re: Suraj Srinivasan; Health; Health; Health

January 2001 (Revised May 2003)
Case

Novartis Pharma: The Business Unit Model

By: Srikant M. Datar, Carin-Isabel Knoop and Cate Reavis

In June 2000, Novartis reorganized its pharmaceutical business to form global business units in oncology, transplantation, ophthalmology, and mature products. The remaining primary care products continued to be managed within global functions (e.g., R&D and marketing).... View Details

Keywords: Restructuring; Recruitment; Product Marketing; Organizational Structure; Problems and Challenges; Health Industry; Health Industry

02 Mar 2023
Blog Post

Women, Work, and the "M" Word

I’m the eldest of three daughters in a medical family. With a urogynecologist and primary care doctor as parents, I grew up thinking it was normal to talk about all topics of women’s health around the dinner table, from menstruation to... View Details

August 2020
Supplement

Sheena Gupta (B)

By: Leslie Perlow and Matthew Preble

Sheena Gupta (B) provides a brief update to how Gupta is thinking about crafting her life in context of the COVID-19 global pandemic. View Details

Keywords: Personal Development and Career; Values and Beliefs; Work-Life Balance; Health Pandemics; Singapore

2001
Chapter

Publicly Funded Science and the Productivity of the Pharmaceutical Industry

By: Rebecca Henderson and Ian Cockburn

U.S. taxpayers funded $14.8 billion of health related research last year, four times the amount that was spent in 1970 in real terms. In this paper we evaluate the impact of these huge expenditures on the technological performance of the pharmaceutical industry. While... View Details

Keywords: Public Sector; Science-Based Business; Research and Development; Sovereign Finance; Pharmaceutical Industry

Find at Harvard

Read Now

10 Mar 2020
News

'They're getting pummeled': Travel industry reeling from coronavirus concerns, anxiety

October 2017 (Revised August 2020)
Case

RB

By: Joshua Margolis, Vincent Dessain and Jerome Lenhardt

As 2016 was approaching its end, Rakesh Kapoor, CEO of RB, one of the world’s major fast moving consumer goods (FMCG) companies, envisioned the prospect of a major acquisition that would add a line of health-related products that promised growth in the developing... View Details

Keywords: Organization Behavior; Corporate Culture; Mergers ＆ Acquisitions; Growth; Geographic Development; Mergers and Acquisitions; Organizational Change and Adaptation; Organizational Culture; Growth and Development Strategy; France

09 Dec 2008
First Look

First Look: December 9, 2008

markets, highlighting concerns as China strives to modernize its financial system to meet global competition and support its fast growing economy. Purchase the note: http://harvardbusinessonline.hbsp.harvard.edu/... View Details

Keywords: Martha Lagace

18 Sep 2007
First Look

First Look: September 18, 2007

activity to distance themselves from competitors. Microfinance: Business, Profitability, and the Creation of Social Value Author:Michael Chu Publication:Chap. 28 in Business Solutions for the Global Poor: Creating Social and Economic... View Details

Keywords: Martha Lagace

Program

Mergers and Acquisitions

this M&A course, you will acquire a critical cross-functional perspective of the mergers and acquisitions process. Through global case studies on the best practices of leading companies, you will learn how to forge strategic partnerships,... View Details

2021
Book

Remote Work Revolution: Succeeding from Anywhere

By: Tsedal Neeley

The rapid and unprecedented changes brought on by COVID-19 have accelerated the transition to remote working, requiring the wholesale migration of nearly entire companies to virtual work in just weeks, leaving managers and employees scrambling to adjust. This massive... View Details

Keywords: Remote Work; Health Pandemics; Employment; Disruption; Organizational Change and Adaptation; Management

Find at Harvard

May 2014 (Revised January 2015)
Case

Vaxess Technologies, Inc.

By: John A. Quelch and Margaret L. Rodriguez

In February 2014, Michael Schrader, chief executive of Vaxess Technologies, Inc., was assessing the startup health care company's 2014 marketing plan. On December 31st, 2013, Vaxess had obtained an exclusive license to a series of patents for a silk protein technology... View Details

Keywords: Vaccine; Cold Chain; Antigen; Temperature Controlled; Developing Markets; Immunization; Health Care and Treatment; Health Pandemics; Global Strategy; Supply Chain; Health; Health Industry; Health Industry